Exclusive

Publication

Byline

Uma Thurman can see 'great positives' in AI

United Kingdom, March 19 -- Uma Thurman doesn't "see the point" of being "nervous" about AI and thinks there are "great positives" to the technology. The 55-year-old actress admitted she has been a "... Read More


Park Place Mall Shooting: What We Know So Far About Tucson Mall Gunfire; Sparks Fear Among Shoppers

India, March 19 -- A shooting has been reported today at Park Place Mall. The mall is located at 5870 E Broadway Boulevard in Tucson, Arizona. According to scanner reports, the shooting took place ins... Read More


Navratri 2026: Dos and don'ts to attract positivity by Jai Madaan

India, March 19 -- Navratri is a time filled with colour, joy, and devotion. Homes are decorated, prayers are offered, and a special festive energy fills the air. But beyond the celebrations and tradi... Read More


Friends save 6-year-old from kidnapping attempt in Telangana, police deny

Hyderabad, March 19 -- Four six-year-old boys thwarted what could have been a kidnapping attempt in Sangareddy town's Dwarka Nagar Colony on Thursday, March 19, by throwing stones at people who tried ... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, March 19 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: Leveraging AS01-induced immune cell reprogramming to modulate immune dysregulation in rheumatoid arthritis

Singapore, March 19 -- The Health Sciences Authority received information related to the study titled 'Leveraging AS01-induced immune cell reprogramming to modulate immune dysregulation in rheumatoid ... Read More


Singapore Clinical Trial: A Phase I/II open label study of DJI136, a DLL3-targeted CAR-T therapy, in adult patients with ES-SCLC

Singapore, March 19 -- The Health Sciences Authority received information related to the study titled 'A Phase I/II open label study of DJI136, a DLL3-targeted CAR-T therapy, in adult patients with ES... Read More


Singapore Clinical Trial: Beamion PANTUMOR 1: A Phase II, multicentre, multicohort, open-label trial to evaluate the efficacy and safety of oral zongertinib (BI 1810631) for the treatment of selected HER2 mutated or overexpressed/amplified solid tumours

Singapore, March 19 -- The Health Sciences Authority received information related to the study titled 'Beamion PANTUMOR 1: A Phase II, multicentre, multicohort, open-label trial to evaluate the effica... Read More


Singapore Clinical Trial: An open-label, multi-center, phase I/Ib study of IEV407 as a single agent and in combination with endocrine therapy in patients with advanced hormone receptor positive, HER2- negative breast cancer

Singapore, March 19 -- The Health Sciences Authority received information related to the study titled 'An open-label, multi-center, phase I/Ib study of IEV407 as a single agent and in combination with... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, March 19 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More